In Brief This Week: Roche, Cepheid; Anagnostics, Ramcon; InCellDx, Labco; Genome Designs; Prometheus | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche has initiated an arbitration hearing against Cepheid in response to Cepheid's decision to terminate its real-time PCR license with Roche, according to GenomeWeb Daily News sister publication PCR Insider. Cepheid had said in October that it was terminating the remainder of its PCR license with Roche "after determining that any patents remaining under the license are not pertinent to Cepheid's future business plans."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.